Other work in HepG2 cells treated with high glucose and in high-fat models of NAFLD found that the methylation status of the NFE2L2 gene was increased, while that of KEAP1 was decreased, leading to decreased NRF2 expression and activity [91]. The gene discussed is NFE2L2; the disease is metabolic dysfunction-associated steatotic liver disease.